KC, F., WJJ, W., HS, W., KP, L., SN, F., & M, S. Switching to Faricimab for Polypoidal Choroidal Vasculopathy with Real-World Outcomes in Refractory Cases – The FAR-PEARL Study Report 1. Dove Medical Press.
Chicago Style (17th ed.) CitationKC, Fong, Wong WJJ, Wong HS, Ling KP, Fong SN, and Shunmugam M. Switching to Faricimab for Polypoidal Choroidal Vasculopathy with Real-World Outcomes in Refractory Cases – The FAR-PEARL Study Report 1. Dove Medical Press.
MLA (9th ed.) CitationKC, Fong, et al. Switching to Faricimab for Polypoidal Choroidal Vasculopathy with Real-World Outcomes in Refractory Cases – The FAR-PEARL Study Report 1. Dove Medical Press.
Warning: These citations may not always be 100% accurate.